Welcome to our dedicated page for XWELL news (Ticker: XWEL), a resource for investors and traders seeking the latest updates and insights on XWELL stock.
XWELL, Inc. (Nasdaq: XWEL) regularly issues news updates that highlight its activities as a global wellness holding company focused on health, beauty, self-care, and biosecurity for people on the go. Company press releases cover developments across its portfolio of brands, including XpresSpa, Naples Wax Center, XpresCheck, and HyperPointe, as well as partnerships and capital markets disclosures.
Readers of this news feed can expect coverage of wellness center openings and expansions, such as new brick-and-mortar locations in Florida and the launch of a wellness retail location in New York City’s Pennsylvania Station. XWELL’s announcements describe these sites as destinations for services like facials, massages, waxing, medical and wellness services, and autonomous massage, along with wellness-focused retail tailored to travelers, commuters, and local communities.
XWELL’s news also frequently addresses its biosecurity and biosurveillance initiatives. Through XpresCheck and HyperPointe, the company reports supporting the CDC’s Traveler-based Genomic Surveillance program in association with Ginkgo Bioworks, contributing to traveler-based pathogen surveillance at U.S. airports. Recent updates describe a global biosecurity strategy that aims to extend traveler-based surveillance models to international travel hubs and large-scale mass gatherings.
In addition, XWELL issues releases about strategic partnerships and brand collaborations, including its expanded partnership with Priority Pass, which allows members to access autonomous massage and other wellness options at XWELL and XpresSpa locations in North America and select international airports. The company has also announced collaborations such as a co-branded eye mask with Ostrichpillow and a partnership naming XWELL the official wellness spa of the Orlando Magic.
Investors and observers following XWEL news will also see financial and regulatory updates, including quarterly results, Nasdaq listing compliance notices, and information about stockholder meetings and capital structure transactions. Together, these news items provide an ongoing view into how XWELL is expanding its wellness footprint, developing biosecurity programs, and managing its public company obligations.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
XWELL, Inc. (Nasdaq: XWEL) announced its financial results for the year ending December 31, 2022, reporting total revenue of $55.9 million, a decrease from $73.7 million in 2021. The net loss attributable to common shareholders was $32.8 million, compared to a net income of $3.3 million the previous year. Key initiatives include the opening of new XpresSpa locations and partnerships to integrate innovative health technologies. The company’s operational adjustments led to a reduction in cash operating costs and the closure of underperforming locations. Financial metrics indicate a working capital of $36.4 million with no long-term debt. XWELL continues to focus on growth in wellness services at airports, expanding its biosurveillance program, and enhancing retail strategies.
XWELL, Inc. (Nasdaq: XWEL) will announce its fiscal year 2022 financial results on April 17, 2023, after market close, followed by a webcast and conference call at 5:00 PM ET. Interested investors are encouraged to listen via the webcast due to limited phone line capacity.
The Company operates four brands: XpresSpa, a leader in airport wellness services with 35 locations; Treat, a travel health brand; XpresCheck, providing COVID-19 testing; and HyperPointe, a digital healthcare analytics firm. XWELL emphasizes the importance of health and wellness solutions for travelers.
Forward-looking statements are included regarding future performance expectations, which are not guaranteed and involve risks.
XWELL plans to submit a Form 12b-25 to the SEC for its Annual Report on Form 10-K for the fiscal year ending December 31, 2022. The company requires extra time to assess a non-cash impairment charge for Q4 2022, granting an additional 15 days for its audit. Total revenue for 2022 is projected at $56 million, with a gross profit margin decline from 44% to 22%. Costs rose to $44 million, and general administrative expenses increased to $31 million. Despite these challenges, XWELL opened five new XpresSpa locations and reduced cash operating costs through the closure of underperforming sites. The 2022 Form 10-K is expected by April 17, 2023.
XWELL has launched a groundbreaking beauty experience at airports by introducing Clockwork’s AI-powered manicure robots in its XpresSpa location at JFK, making it the first airport globally to offer this service. The robots, known as Clockwork MiNiCURE, provide efficient and high-quality manicures in under 10 minutes. XWELL plans to expand this innovative service by deploying up to 25 robots across its 31 spa locations soon. This partnership showcases XWELL's commitment to enhancing wellness offerings for travelers while embracing cutting-edge technology.
FAQ
What is the current stock price of XWELL (XWEL)?
What is the market cap of XWELL (XWEL)?
